Genome sequencing in pregnancy with normal ultrasound to see if more information helps families
Official title: guideSEQ: Genomic Understanding, Impact, Decision & Ethics in Prenatal Sequencing
Run by Columbia University · NCT07610590 · Data updated 2026-11-12
This study tests whether genome sequencing during pregnancy can provide useful information for families when ultrasounds look normal.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1042 (estimated) |
| Sponsor | Columbia University Academic / other |
| Locations | 3 sites (Boston, Massachusetts and 2 other locations) |
| Status | Recruiting |
| Started | April 29, 2026 |
| Main results expected | July 31, 2029 |
| Study ends | July 31, 2029 |
| Registry record updated | July 15, 2026 |
| Trial ID | NCT07610590 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Pregnancies without major fetal anomalies planning CVS or amniocentesis and cared for with a certified genetic counselor.
✕Probably not a fit
Pregnancies with major fetal anomalies or families unwilling to participate in 1 year of follow-up may not benefit.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This multicenter study observes how prenatal whole genome sequencing performs in pregnancies without fetal structural anomalies. It compares sequencing results to standard prenatal testing to understand what additional variants might be found and how these findings could affect clinical care. The study also explores how parents decide what genetic information to receive and how it impacts their pregnancy experience, with follow-up through one year after birth. Researchers will examine the frequency of pathogenic or uncertain variants and the psychosocial needs of parents. Participants include pregnancies undergoing CVS or amniocentesis with eligible criteria and involve certified genetic counselors in care.
Why it matters
Potential benefit: If successful, routine prenatal genome sequencing could provide actionable genetic information that guides care and decision-making for families.
How similar studies have gone: Prior prenatal sequencing studies have shown potential to identify additional genetic information in select cases, but this approach remains investigational in normal-appearing pregnancies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient planned chorionic villus sampling (CVS) or amniocentesis in the absence of major fetal structural anomalies (minor anomalies are eligible, the HPO (Human Phenotype Ontology) will not be used by the analyst) * Certified genetic counselor involved in care Exclusion Criteria: * A major structural anomaly * Maternal or paternal age less than 18 years old * Parental unwillingness to participate in 1 year of postnatal follow-up * Language barrier (non-English or Spanish speaking)
Where it's running
-
Columbia University Irving Medical Center (CUIMC)
New York, New York, United States Recruiting -
Boston Childrens Hospital
Boston, Massachusetts, United States Active not recruiting -
New York Genome Center
New York, New York, United States Active not recruiting
Study contacts
- Principal investigator: Ronald Wapner, MD — Columbia University Irving Medical Center (CUIMC)
- Study coordinator: Camila Zarate, MPH
- Email: cz2888@cumc.columbia.edu
- Phone: 646-300-0197
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
See if non-invasive fetal DNA testing after early miscarriage supports mental health and follow-up care
This study tests whether doing non-invasive prenatal testing from a blood sample after an early miscarriage helps with mental well-being and guides care over the next year.
-
Video-Only vs Standard Informed Consent for Amniocentesis or CVS in Pregnant Women
This study tests whether video-based education helps reduce anxiety and improve decision readiness for invasive prenatal testing in pregnant women.
-
Whole-genome sequencing in fetuses with unexplained ultrasound findings
Doctors will test whether whole-genome sequencing can find genetic reasons for fetal abnormalities when standard tests are negative, and how the results might influence pregnancy decisions.
-
Normal fetal brain growth charts from routine MRI scans
This project will create MRI-based charts of normal fetal brain volume using past routine scans from four French hospitals to help doctors interpret fetal brain images.
-
Registry for patients with rare diseases
This study is creating a central registry for people with rare diseases to help connect them with researchers and improve treatments.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.